January 2, 2026

Celcuity Inc. (CELC) Stock Report: A Biotechnology Pioneer with a 10.79% Potential Upside

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company headquartered in Minneapolis, is making waves in the healthcare sector with its innovative approach to cancer treatment. Primarily..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a Potential 21% Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB) operates at the forefront of the healthcare sector, specializing in the development and sale of sophisticated instrumentation, consumables, and services for..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and Promising Target Price

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $1.14 billion,..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring the 203% Upside Potential in Biotechnology

Bicycle Therapeutics plc (NASDAQ: BCYC), a UK-based biotechnology firm, is capturing investor attention with a staggering potential upside of 203.67%. This figure, combined with the company’s..

Upstream Bio, Inc. (UPB) Stock Analysis: Biotech Innovator with a 75% Potential Upside

Upstream Bio, Inc. (UPB) has emerged as a promising player in the biotechnology sector, particularly within the niche of inflammatory disease treatments. With its focus on..

Personalis, Inc. (PSNL) Stock Analysis: Exploring a 38% Upside Potential in the Healthcare Diagnostics Sector

Investors with an eye on the healthcare diagnostics sector might find Personalis, Inc. (NASDAQ: PSNL) an intriguing opportunity, especially given the significant 38.19% potential upside based..

Surmodics, Inc. (SRDX) Stock Report: Navigating Challenges with Innovative Medical Solutions

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices, is certainly an intriguing entity for investors with a penchant for..

REGENXBIO Inc. (RGNX) Investor Outlook: Exploring a 110.86% Upside Potential in Gene Therapy Innovation

REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector with its innovative approach to gene therapy, particularly through its proprietary NAV Technology Platform. This clinical-stage..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring a 99.97% Potential Upside

ArriVent BioPharma, Inc. (AVBP), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline and a staggering potential upside of 99.97%...

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 115% Potential Upside Amidst Market Challenges

Investors with an eye on the healthcare sector may find Treace Medical Concepts, Inc. (NASDAQ: TMCI) a compelling yet challenging opportunity. As a player in the..

CeriBell, Inc. (CBLL) Stock Analysis: Unpacking a 28.33% Potential Upside in the Medical Device Arena

CeriBell, Inc. (CBLL), a healthcare company specializing in medical devices, is drawing significant investor attention. With a market capitalization of $813.51 million, CeriBell is positioning itself..

Oruka Therapeutics, Inc. (ORKA) Investor Outlook: 63% Upside Potential Sparks Interest in Biotech Innovator

Oruka Therapeutics, Inc. (ORKA), a clinical-stage biopharmaceutical company headquartered in Menlo Park, California, is capturing attention in the healthcare sector with its promising pipeline of monoclonal..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 42.78% Upside Potential in the Biotech Sector

Theravance Biopharma, Inc. (NASDAQ: TBPH) is emerging as a compelling opportunity for investors seeking exposure in the biotechnology sector. With a market capitalization of $948.08 million..

Iovance Biotherapeutics, Inc. (IOVA) Stock Report: Exploring a Potential 205% Upside Amidst Biotech Innovations

Investors are keeping a keen eye on Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotech firm with a market capitalization of $1.08 billion, as it navigates the..

Tectonic Therapeutic (TECX) Stock Analysis: Unveiling a 277% Upside Potential in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing investor attention with an eye-catching potential upside of 277.35%, according to consensus analyst ratings. As a promising player in..

Verastem, Inc. (VSTM) Investor Outlook: Exploring a Potential 107% Upside in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company dedicated to the development and commercialization of cancer treatments, has been capturing investor attention with its robust pipeline and..

Myriad Genetics, Inc. (MYGN): Investor Outlook Reveals 38% Upside Potential Amid Mixed Ratings

Investors eyeing the healthcare sector may find Myriad Genetics, Inc. (NASDAQ: MYGN) a compelling, albeit complex, opportunity in the diagnostics and research industry. With a current..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a Potential 178% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS) is garnering attention from investors as a promising player in the healthcare sector, specifically within the drug manufacturers specializing in specialty and..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 101.61% Upside Potential in the Healthcare Sector

Individual investors looking to capitalize on potential growth opportunities in the healthcare sector may find Bioventus Inc. (NASDAQ: BVS) an intriguing prospect. With a focus on..

PureTech Health plc (PRTC) Stock Analysis: A Biotech Growth Story with 542.7% Revenue Surge

PureTech Health plc (NASDAQ: PRTC) stands out as a dynamic player in the biotechnology sector, leveraging its innovative approach to develop and commercialize transformative medical solutions...

Search

Funds

January 2, 2026

Search

Funds

January 2, 2026

FTSE 100

Funds